Myomo (NYSE:MYO) announced that it received authorization to be a Medicare provider through the Centers for Medicare & Medicaid Services. CMS, under the U.S. Dept. of Health and Human Services, now includes Cambridge, Mass.-based Myomo in its Medicare Supplier Directory at Medicare.gov, which enables Myomo to bill Medicare directly when it delivers its MyoPro orthosis in […]
Myomo launches MyoCare
Myomo (NYSE:MYO) announced today that it launched its MyoCare program for providing support to first-year users of its MyoPro powered brace. MyoCare offers expanded support to current and future clients who receive their MyoPro directly from the Cambridge, Mass.-based company, at no additional cost. Anyone who obtained the MyoPro from an authorized orthotics & prosthetics clinic […]
COVID-19 upends medtech’s financial outlook
The uncertain times brought on by the COVID-19 pandemic have affected businesses worldwide, and several sectors of medtech industry are projecting hits to their bottom lines. A number of companies have announced decisions to withdraw financial guidance, cut hours and/or staff, among other major business decisions. Initial impacts of the global pandemic on Wall Street […]
Myomo drops on Q4 losses
Myomo (NYSE:MYO) shares took a hit today on fourth-quarter results that missed the consensus forecast for earnings but topped the revenue projections. The Cambridge, Mass.-based commercial-stage medical robotics company yesterday evening posted losses of $2.8 million, or -$4.81 per share, on sales of $1.5 million for the three months ended Dec. 31, 2019, for a 2.6% […]
Myomo closes $15m public offering
Myomo (NYSE:MYO) announced that it closed its previously announced underwritten public offering of common stock or common stock equivalents for gross proceeds of $15 million. The offering included more than 2.1 million shares of Cambridge, Mass.–based Myomo’s common stock or equivalents, along with an equal amount of investor warrants to purchase one share of common stock […]
Myomo shares down on news of $15m public offering
Shares of Myomo (NYSE:MYO) took a dive in price today after the commercial-stage medical robotics company announced it would raise $15 million from a public offering. MYO shares were down nearly 45% to $6.46 apiece by the afternoon. The company — maker of the MyoPro upper limb orthosis — is selling more than 2.1 million shares […]
Myomo stock sees week of volatility
Investors have traded millions of shares in commercial-stage medical robotics company Myomo (NYSE:MYO) this week, with the company saying it is unaware of what is causing the trading volatility. The Cambridge, Mass.–based company on Jan. 30 enacted a 1-for-30 reverse stock split, with stocks slumping for a few days before doubling in value on Tuesday and then […]
Myomo announces 1-for-30 stock split, sees shares drop
Commercial-stage medical robotics company Myomo (NYSE:MYO) shares plummeted today after it announced the decision of its board of directors to effect a reverse stock split of the company’s common stock at a 1-for-30 ratio. Shares of MYO were down nearly –4% to $8.70 per share at market close today. The decision followed approval of a reverse […]
Myomo slides on missed Q3 projections
Myomo (NYSE:MYO) shares plummeted today on third-quarter sales shortcomings and a bottom-line dip. The Cambridge, Mass.–based wearable medical robotics company posted losses of -$2.8 million, or -16¢ per share, on sales of $606,619 for the three months ended Sept. 30, for a 5.2% bottom-line slide on a sales decline of 0.4%. Adjusted to exclude one-time […]
Myomo launches OUS licensing development program
Myomo today said it launched a business development program to help bring its MyoPro orthotic product line to more markets outside of the U.S. The Cambridge, Mass.-based company will pursue technology licensing arrangements with international partners that can manufacture and distribute its MyoPro products to rehabilitation hospitals and home markets. Get the full story on our […]
Myomo closes $6m funding round
Myomo said today that it closed a $6.4 million round of financing. The Cambridge, Mass.-based wearable medical robotics company said that it floated approximately four million shares of its common stock at $1.40 per share for gross proceeds of approximately $5.5 million. The offering included a fully-exercised underwriter’s option for an additional 592,500 shares of […]
- 1
- 2
- 3
- 4
- Next Page »
